PDK1 Recruitment to the SHPS-1 Signaling Complex Enhances Insulin-like Growth Factor-I-stimulated AKT Activation and Vascular Smooth Muscle Cell Survival
Xinchun Shen(Nanjing University of Finance and Economics), David R. Clemmons(University of North Carolina at Chapel Hill)
Cited by 16
Related Papers
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
|The Lancet|2001|643
Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-C
|New England Journal of Medicine|1979|367
Reduction of Plasma Immunoreactive Somatomedin C during Fasting in Humans*
|The Journal of Clinical Endocrinology & Metabolism|1981|366